Loading…

Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children

Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching,...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 2019-07, Vol.144 (1), p.1
Main Authors: Boruta, Mary, Boruta, Richard, Li, Jennifer
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273
cites cdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273
container_end_page
container_issue 1
container_start_page 1
container_title Pediatrics (Evanston)
container_volume 144
creator Boruta, Mary
Boruta, Richard
Li, Jennifer
description Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals
doi_str_mv 10.1542/peds.2019-0909
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2251105609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2258735659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</originalsourceid><addsrcrecordid>eNpdkD1PwzAURS0EoqWwMqJILGVIeXbiOB6rio9KFQyUOXLsFzUliYPdIPXfk9DCwPSkp3Ovrg4h1xRmlMfsvkXjZwyoDEGCPCFjCjINYyb4KRkDRDSMAfiIXHi_BYCYC3ZORhGlgtNYjMnLXJcmeOva1qH3pW2C9QadaveBavr_vm53tg6WdevsF9bY7IKpdcFK6Y8fEG1xF5RNsNiUlXHYXJKzQlUer453Qt4fH9aL53D1-rRczFehjpJoF7JYy5gVIi0o50aqHJTUXGmaiARzCRoRhATFchC5Tk1qDEZGp5AKmQAT0YRMD739rs8O_S6rS6-xqlSDtvMZY5xS4AnIHr39h25t55p-3UClIuIJH6jZgdLOeu-wyFpX1srtMwrZYDobTGeD6Www3QdujrVdXqP5w3_VRt91fnhq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258735659</pqid></control><display><type>article</type><title>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Boruta, Mary ; Boruta, Richard ; Li, Jennifer</creator><creatorcontrib>Boruta, Mary ; Boruta, Richard ; Li, Jennifer</creatorcontrib><description>Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals &lt;2 years old.1 At 4 months of age, 67% of children have daily regurgitation. Parents report a perceived problem with GER in 23% of 6-month-old infants.2 This high rate of concern results in GER being a common complaint in outpatient and inpatient settings. Combined with the ready availability of acid suppression therapy, this has led to increased prescribing of both H2RAs and PPIs in both infants and older children.3,4 Acid suppression therapy has been previously viewed as benign; however, recent research has revealed that these medications may carry risk.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.2019-0909</identifier><identifier>PMID: 31175147</identifier><language>eng</language><publisher>United States: American Academy of Pediatrics</publisher><subject>Acids ; Antacids ; Child ; Child, Preschool ; Children ; Gastroesophageal Reflux ; Histamine ; Humans ; Infants ; Proton pump inhibitors ; Regurgitation ; Secondary Prevention ; Treatment Outcome ; Vomiting</subject><ispartof>Pediatrics (Evanston), 2019-07, Vol.144 (1), p.1</ispartof><rights>Copyright American Academy of Pediatrics Jul 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</citedby><cites>FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31175147$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boruta, Mary</creatorcontrib><creatorcontrib>Boruta, Richard</creatorcontrib><creatorcontrib>Li, Jennifer</creatorcontrib><title>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals &lt;2 years old.1 At 4 months of age, 67% of children have daily regurgitation. Parents report a perceived problem with GER in 23% of 6-month-old infants.2 This high rate of concern results in GER being a common complaint in outpatient and inpatient settings. Combined with the ready availability of acid suppression therapy, this has led to increased prescribing of both H2RAs and PPIs in both infants and older children.3,4 Acid suppression therapy has been previously viewed as benign; however, recent research has revealed that these medications may carry risk.</description><subject>Acids</subject><subject>Antacids</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Gastroesophageal Reflux</subject><subject>Histamine</subject><subject>Humans</subject><subject>Infants</subject><subject>Proton pump inhibitors</subject><subject>Regurgitation</subject><subject>Secondary Prevention</subject><subject>Treatment Outcome</subject><subject>Vomiting</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpdkD1PwzAURS0EoqWwMqJILGVIeXbiOB6rio9KFQyUOXLsFzUliYPdIPXfk9DCwPSkp3Ovrg4h1xRmlMfsvkXjZwyoDEGCPCFjCjINYyb4KRkDRDSMAfiIXHi_BYCYC3ZORhGlgtNYjMnLXJcmeOva1qH3pW2C9QadaveBavr_vm53tg6WdevsF9bY7IKpdcFK6Y8fEG1xF5RNsNiUlXHYXJKzQlUer453Qt4fH9aL53D1-rRczFehjpJoF7JYy5gVIi0o50aqHJTUXGmaiARzCRoRhATFchC5Tk1qDEZGp5AKmQAT0YRMD739rs8O_S6rS6-xqlSDtvMZY5xS4AnIHr39h25t55p-3UClIuIJH6jZgdLOeu-wyFpX1srtMwrZYDobTGeD6Www3QdujrVdXqP5w3_VRt91fnhq</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Boruta, Mary</creator><creator>Boruta, Richard</creator><creator>Li, Jennifer</creator><general>American Academy of Pediatrics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20190701</creationdate><title>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</title><author>Boruta, Mary ; Boruta, Richard ; Li, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acids</topic><topic>Antacids</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Gastroesophageal Reflux</topic><topic>Histamine</topic><topic>Humans</topic><topic>Infants</topic><topic>Proton pump inhibitors</topic><topic>Regurgitation</topic><topic>Secondary Prevention</topic><topic>Treatment Outcome</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boruta, Mary</creatorcontrib><creatorcontrib>Boruta, Richard</creatorcontrib><creatorcontrib>Li, Jennifer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boruta, Mary</au><au>Boruta, Richard</au><au>Li, Jennifer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>144</volume><issue>1</issue><spage>1</spage><pages>1-</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><abstract>Acid suppression therapy, in the form of histamine H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), is a common treatment in pediatrics for management of gastroesophageal reflux (GER). Symptoms commonly associated with GER in younger children include frequent emesis, back arching, fussiness, and discomfort. GER symptoms are reported in 10.3% of all children, with symptoms even more commonly noted in individuals &lt;2 years old.1 At 4 months of age, 67% of children have daily regurgitation. Parents report a perceived problem with GER in 23% of 6-month-old infants.2 This high rate of concern results in GER being a common complaint in outpatient and inpatient settings. Combined with the ready availability of acid suppression therapy, this has led to increased prescribing of both H2RAs and PPIs in both infants and older children.3,4 Acid suppression therapy has been previously viewed as benign; however, recent research has revealed that these medications may carry risk.</abstract><cop>United States</cop><pub>American Academy of Pediatrics</pub><pmid>31175147</pmid><doi>10.1542/peds.2019-0909</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0031-4005
ispartof Pediatrics (Evanston), 2019-07, Vol.144 (1), p.1
issn 0031-4005
1098-4275
language eng
recordid cdi_proquest_miscellaneous_2251105609
source EZB-FREE-00999 freely available EZB journals
subjects Acids
Antacids
Child
Child, Preschool
Children
Gastroesophageal Reflux
Histamine
Humans
Infants
Proton pump inhibitors
Regurgitation
Secondary Prevention
Treatment Outcome
Vomiting
title Acid Suppression Therapy and Symptom Improvement (or Lack Thereof) in Children
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acid%20Suppression%20Therapy%20and%20Symptom%20Improvement%20(or%20Lack%20Thereof)%20in%20Children&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Boruta,%20Mary&rft.date=2019-07-01&rft.volume=144&rft.issue=1&rft.spage=1&rft.pages=1-&rft.issn=0031-4005&rft.eissn=1098-4275&rft_id=info:doi/10.1542/peds.2019-0909&rft_dat=%3Cproquest_cross%3E2258735659%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c363t-24c942f78f155d9ab0a9c5ac1676eb90cee0790a2b07bc8d8dde3dc8087960273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2258735659&rft_id=info:pmid/31175147&rfr_iscdi=true